PCV38 BOSENTAN IS A COST-EFFECTIVE TREATMENT FOR UNITED KINGDOM PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION OF WHO CLASS III
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70626-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)70626-4/fulltext
Section Title :
Section Order :
356
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70626-4&doi=10.1016/S1098-3015(10)70626-4